677 related articles for article (PubMed ID: 26857415)
21. Characteristics of mild cognitive impairment tending to convert into Alzheimer's disease or dementia with Lewy bodies: A follow-up study in a memory clinic.
Kondo D; Ota K; Kasanuki K; Fujishiro H; Chiba Y; Murayama N; Sato K; Hirayasu Y; Arai H; Iseki E
J Neurol Sci; 2016 Oct; 369():102-108. PubMed ID: 27653873
[TBL] [Abstract][Full Text] [Related]
22. Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
Beretta L; Caminiti SP; Santangelo R; Magnani G; Ferrari-Pellegrini F; Caffarra P; Perani D
Neuropsychologia; 2019 Oct; 133():107174. PubMed ID: 31446008
[TBL] [Abstract][Full Text] [Related]
23. Differential diagnosis of MCI with Lewy bodies and MCI due to Alzheimer's disease by visual assessment of occipital hypoperfusion on SPECT images.
Nakata T; Shimada K; Iba A; Oda H; Terashima A; Koide Y; Kawasaki R; Yamada T; Ishii K
Jpn J Radiol; 2024 Mar; 42(3):308-318. PubMed ID: 37861956
[TBL] [Abstract][Full Text] [Related]
24. ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Smailagic N; Vacante M; Hyde C; Martin S; Ukoumunne O; Sachpekidis C
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010632. PubMed ID: 25629415
[TBL] [Abstract][Full Text] [Related]
25. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic imaging of dementia with Lewy bodies by susceptibility-weighted imaging of nigrosomes versus striatal dopamine transporter single-photon emission computed tomography: a retrospective observational study.
Kamagata K; Nakatsuka T; Sakakibara R; Tsuyusaki Y; Takamura T; Sato K; Suzuki M; Hori M; Kumamaru KK; Inaoka T; Aoki S; Terada H
Neuroradiology; 2017 Jan; 59(1):89-98. PubMed ID: 28035426
[TBL] [Abstract][Full Text] [Related]
27. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
[TBL] [Abstract][Full Text] [Related]
28. Validation of the cingulate island sign with optimized ratios for discriminating dementia with Lewy bodies from Alzheimer's disease using brain perfusion SPECT.
Imabayashi E; Soma T; Sone D; Tsukamoto T; Kimura Y; Sato N; Murata M; Matsuda H
Ann Nucl Med; 2017 Aug; 31(7):536-543. PubMed ID: 28547521
[TBL] [Abstract][Full Text] [Related]
29. Clinical profiles of dementia with Lewy bodies with and without Alzheimer's disease-like hypometabolism.
Chiba Y; Fujishiro H; Ota K; Kasanuki K; Arai H; Hirayasu Y; Sato K; Iseki E
Int J Geriatr Psychiatry; 2015 Mar; 30(3):316-23. PubMed ID: 24839913
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of 3-dimensional stereotactic surface projection FDG PET images for the diagnosis of dementia.
Kim J; Cho SG; Song M; Kang SR; Kwon SY; Choi KH; Choi SM; Kim BC; Song HC
Medicine (Baltimore); 2016 Dec; 95(49):e5622. PubMed ID: 27930593
[TBL] [Abstract][Full Text] [Related]
31. [18F]FDG-PET study in dementia with Lewy bodies and Alzheimer's disease.
Okamura N; Arai H; Higuchi M; Tashiro M; Matsui T; Hu XS; Takeda A; Itoh M; Sasaki H
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Feb; 25(2):447-56. PubMed ID: 11294488
[TBL] [Abstract][Full Text] [Related]
32. Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies.
Iizuka T; Kameyama M
Ann Nucl Med; 2016 Jul; 30(6):421-9. PubMed ID: 27098829
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of dementia with Lewy bodies: can
Sakamoto F; Shiraishi S; Tsuda N; Hashimoto M; Tomiguchi S; Ikeda M; Yamashita Y
Br J Radiol; 2017 Feb; 90(1070):20160156. PubMed ID: 27897064
[TBL] [Abstract][Full Text] [Related]
34. Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.
Gilman S; Koeppe RA; Little R; An H; Junck L; Giordani B; Persad C; Heumann M; Wernette K
Exp Neurol; 2005 Feb; 191 Suppl 1():S95-S103. PubMed ID: 15629765
[TBL] [Abstract][Full Text] [Related]
35. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R
J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523
[TBL] [Abstract][Full Text] [Related]
36. Direct comparison study between FDG-PET and IMP-SPECT for diagnosing Alzheimer's disease using 3D-SSP analysis in the same patients.
Nihashi T; Yatsuya H; Hayasaka K; Kato R; Kawatsu S; Arahata Y; Iwai K; Takeda A; Washimi Y; Yoshimura K; Mizuno K; Kato T; Naganawa S; Ito K
Radiat Med; 2007 Jul; 25(6):255-62. PubMed ID: 17634878
[TBL] [Abstract][Full Text] [Related]
37. Metabolic Network Topology of Alzheimer's Disease and Dementia with Lewy Bodies Generated Using Fluorodeoxyglucose Positron Emission Tomography.
Imai M; Tanaka M; Sakata M; Wagatsuma K; Tago T; Toyohara J; Sengoku R; Nishina Y; Kanemaru K; Ishibashi K; Murayama S; Ishii K
J Alzheimers Dis; 2020; 73(1):197-207. PubMed ID: 31771066
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic and prognostic value of EEG in prodromal dementia with Lewy bodies.
van der Zande JJ; Gouw AA; van Steenoven I; van de Beek M; Scheltens P; Stam CJ; Lemstra AW
Neurology; 2020 Aug; 95(6):e662-e670. PubMed ID: 32636325
[TBL] [Abstract][Full Text] [Related]
39. Value of analyzing deep gray matter and occipital lobe perfusion to differentiate dementia with Lewy bodies from Alzheimer's disease.
Shimizu S; Hanyu H; Hirao K; Sato T; Iwamoto T; Koizumi K
Ann Nucl Med; 2008 Dec; 22(10):911-6. PubMed ID: 19142710
[TBL] [Abstract][Full Text] [Related]
40. Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography.
Koeppe RA; Gilman S; Junck L; Wernette K; Frey KA
Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S67-76. PubMed ID: 18632004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
